In a remote location outside Washington D.C., a group of the nation’s most powerful political, business, and medical leaders sat at a large table in a super-secret, super-secure conference room.
“We’ve discovered a new COVID variant,” Dr. Rachel Kielbasa, head of the Center for Disease Commerce, announced. “Over a hundred cases in Texas within the last month, forty-four cases in Florida the last two weeks.”
The people around the conference room smiled. A new variant out of Texas and Florida was a good thing. It would show those yahoos.
“So why all this secrecy and rigamarole, what’s another variant?” Albert Moola asked. He was the CEO of Liezer, a giant pharmaceutical concern.
“Liezer’s vaccine drops to zero effectiveness in two days,” Kielbasa responded.
“So people will need a new booster every two days. That’s a lot of shots, but with adequate funding from the government, I’m sure Liezer can rise…
View original post 1,162 more words